In patients with cystic fibrosis (CF), the emergence of hypermutable Pseudomonas aeruginosa drives the selection of P. aeruginosa variants that are efficiently adapted to the inflamed lungs of these patients.
Publication
The Journal of infectious diseases, 2009, Vol 200, Issue 1, p118